Uroxatral
Product Images NDC 16590-279

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Uroxatral (NDC 16590-279). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Uroxatral10mg Label)

This is a medication package of Alfuzosin Hydrochloride extended-release tablets. Each tablet contains 10mg of Alfuzosin Hydrochloride and is distributed by Sanofi-Aventis US LLC. It is intended to relieve symptoms of pain, nausea, and constipation associated with benign prostatic hyperplasia. The tablets are packaged in a bottle that contains 30 pills. The lot number is A3 and the expiration date is March 2012. The bottle label contains a cautionary statement, stating that federal law prohibits the unauthorized dispensing of this medication.*

FDA Label Image

Figure 1 Image (Uroxatral Fig1)

This is a graph showing the Aliuzosin plasma concentration (measured in ng/mL) at different times (measured in hours) after administration. The horizontal axis represents time while the vertical axis represents concentration.*

FDA Label Image

Figure Image 2 (Uroxatral Fig2)

FDA Label Image

Figure Image 3 (Uroxatral Fig3)

FDA Label Image

Figure Image 4 (Uroxatral Fig4)

FDA Label Image

Figure Image 5 (Uroxatral Fig5)

FDA Label Image

Figure Image 6 (Uroxatral Fig6)

FDA Label Image

Figure Image 7 (Uroxatral Fig7)

FDA Label Image

Structure Image (Uroxatral Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.